The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
about
Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese childrenTetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistanceAntibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenesEfficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study.Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind studyAntibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000.Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non-Typhoidal Salmonella Species in Korea: A KONSAR Study Conducted in 2011.Moraxella catarrhalis: from emerging to established pathogen.Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.In vitro and In vivo activities of LB 10827, a new oral cephalosporin, against respiratory pathogensIn vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections.In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanismsSusceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countriesEvaluation of the clinical microbiology profile of moxifloxacin.Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infectionMoxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.The impact of genomics and related technologies on the search for new antibiotics.Controlling acute bacterial maxillary sinusitis.Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents.Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trialsA Comparison of Cefditoren Pivoxil 8-12 mg/kg/day and Cefditoren Pivoxil 16-20 mg/kg/day in Treatment of Children With Acute Presumed Bacterial Rhinosinusitis: A Prospective, Randomized, Investigator-Blinded, Parallel-Group Study.Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan.Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelinesLimited spread of penicillin-nonsusceptible pneumococci, Skåne County, SwedenEmergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistanceHidden epidemic of macrolide-resistant pneumococci.Nasopharyngeal Carriage, Antibiotic Resistance and Serotype Distribution of Streptococcus Pneumoniae among Healthy Adolescents in Zahedan.Moxifloxacin in respiratory tract infections.Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.Role of gemifloxacin in community-acquired pneumonia.Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated from the nasopharynges of asymptomatic children and molecular analysis of S. pneumoniae and H. influenzae strain replacement in the nasopharynx.Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia.The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.Assessment of attitudes and practices of young Malaysian adults about antibiotics use: a cross-sectional study.Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae.
P2860
Q21245788-03704F73-A190-4EE1-803D-4552B8764484Q24548472-F824B9F2-55F4-4A0C-8079-05EC67EA8733Q24600215-5EB14EE9-CDC8-493D-8466-4E1350D7558DQ24813259-E61DB2D2-803C-4B0C-87B4-DEE8D3A250B0Q30477432-03E795BC-4301-44BB-83A1-039CCC0E0665Q30812493-D7C216E8-06B3-49D9-AEAB-5F469F69152EQ33705711-BB9FC6E0-6435-4EE6-BD37-26163A625B1FQ33879489-25952129-69A7-48CC-AA99-870D137188DAQ33906182-1EA0A9B1-7B28-43D5-8EAE-5B2D9D57DCB3Q33946945-B532D271-2BA4-45E6-8E92-3F7576A1535CQ33980926-314E6353-67F0-4E3D-89A1-8C61B3C08ACBQ33981178-930BBD0C-754A-4E22-A33C-220C482906CAQ33982849-CCD20E16-8924-4DB9-BA63-1D6F18D6EC79Q34105521-0869C12D-3C72-44AD-95FF-62AD6A8FCE76Q34183540-E02D7B9F-537B-453E-94D1-EB0A9E8B07E5Q34223608-1781DBD2-3134-4647-8506-E95C2AF28FAEQ34240856-659F5E0D-A944-4C80-BC02-50E440822DACQ34498620-A4152147-9828-4F83-8F24-E10C7A0120AAQ34534478-6E69A22C-A488-467A-9CDD-DA12E7892DC5Q34974823-74B7AD8C-883E-4DF3-A1B2-54FA5619EB5AQ35047705-F0B3F217-15A3-4C95-A8C0-7AA2C888F312Q35176294-F8A31EE5-CE80-45C1-96FC-91D73AFDAEB3Q35586779-11953F63-B9FA-416C-AC38-4EDD3C0939D5Q35608368-342FC139-F275-47CE-863F-5D0A86459183Q35672378-5E9FB0A6-2E06-4662-8601-FF025422B4ABQ35784460-34943554-8046-4806-8435-9740AE570B27Q35809115-CF4DC3C3-D101-4622-ACCB-74BAA2EF5E63Q35880428-1A9C6D5F-ECFB-4CA5-9F17-AFE9167FE8E5Q36009392-9BCA0665-3516-42FC-8530-4515A1DEC3B5Q36009405-99DE91CB-DE6C-414A-9869-B945D0502167Q36022452-68B72AD5-06D7-4B36-A67D-F88B54B81A37Q36066098-FC732792-FA58-444A-9B01-E0368CE19431Q36487417-73F8A763-2973-4A9B-B28A-A6FA3CCC9C21Q37205116-FD804B00-C69E-4E95-AFC9-8DEB82391980Q37228717-85EA7718-FF86-44FE-B25F-C99B7EB6DD30Q37511264-EA8FE044-EB9D-4F3F-B5CA-DCA5E5AAC9E7Q38023661-6E3F5DB8-094F-4DEE-9A80-9FD0B54CA084Q38217504-85228A76-56F5-46DB-A274-F0C0C47C17BBQ38687366-1FB00666-5A87-4D97-8EEA-1A7573EFA108Q39476866-73D48245-A321-4DB2-991E-6C23EBBF6F9F
P2860
The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The Alexander Project 1996-199 ...... respiratory tract infections.
@ast
The Alexander Project 1996-199 ...... respiratory tract infections.
@en
type
label
The Alexander Project 1996-199 ...... respiratory tract infections.
@ast
The Alexander Project 1996-199 ...... respiratory tract infections.
@en
prefLabel
The Alexander Project 1996-199 ...... respiratory tract infections.
@ast
The Alexander Project 1996-199 ...... respiratory tract infections.
@en
P2860
P356
P1476
The Alexander Project 1996-199 ...... respiratory tract infections.
@en
P2093
Felmingham D
Grüneberg RN
P2860
P304
P356
10.1093/JAC/45.2.191
P407
P577
2000-02-01T00:00:00Z